Difficulty: Medium
Average Score: 63%
Practice
Which of the following barbiturates has the shortest half-life?
Correct answer
C
Rationale
In pharmacology of CNS drugs, understanding the pharmacokinetic properties of different barbiturates is crucial for safe and effective prescribing. In this case, the correct answer is C) Methohexital, which has the shortest half-life among the listed barbiturates.
Methohexital is an ultra-short-acting barbiturate primarily used for anesthesia induction due to its rapid onset and short duration of action. Its short half-life means it is quickly metabolized and eliminated from the body, making it suitable for procedures requiring brief sedation periods.
Now, let's analyze why the other options are incorrect:
- A) Secobarbital: Secobarbital has a longer half-life compared to Methohexital, making it unsuitable for procedures requiring rapid recovery.
- B) Pentobarbital: Pentobarbital has a longer half-life as well, making it more suitable for longer sedation or anesthesia maintenance.
- D) Amobarbital: Amobarbital also has a longer half-life compared to Methohexital, making it less ideal for short sedation periods.
Educationally, understanding the pharmacokinetic differences among barbiturates is essential for healthcare professionals to make informed decisions when choosing the appropriate agent for sedation or anesthesia based on the desired duration of action and clinical context. This knowledge ensures patient safety and optimal outcomes in clinical practice.
Methohexital is an ultra-short-acting barbiturate primarily used for anesthesia induction due to its rapid onset and short duration of action. Its short half-life means it is quickly metabolized and eliminated from the body, making it suitable for procedures requiring brief sedation periods.
Now, let's analyze why the other options are incorrect:
- A) Secobarbital: Secobarbital has a longer half-life compared to Methohexital, making it unsuitable for procedures requiring rapid recovery.
- B) Pentobarbital: Pentobarbital has a longer half-life as well, making it more suitable for longer sedation or anesthesia maintenance.
- D) Amobarbital: Amobarbital also has a longer half-life compared to Methohexital, making it less ideal for short sedation periods.
Educationally, understanding the pharmacokinetic differences among barbiturates is essential for healthcare professionals to make informed decisions when choosing the appropriate agent for sedation or anesthesia based on the desired duration of action and clinical context. This knowledge ensures patient safety and optimal outcomes in clinical practice.